AN2 Therapeutics (ANTX) Accounts Payables (2021 - 2026)
AN2 Therapeutics (ANTX) recorded Accounts Payables of $1.97 million in Q2 2026, down 6.9% from $2.11 million a year earlier and down 24.8% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Accounts Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics reported Accounts Payables of $3.02 million, down 8.9% from FY2024.
- Annual Accounts Payables has a four-year compound annual growth rate of 29.8% (FY2021 to FY2025).
- Across earlier years, Accounts Payables came in at $3.32 million in FY2024 (+24.0%), $2.68 million in FY2023 (+26.1%), $2.12 million in FY2022 (+99.6%) and $1.06 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Accounts Payables since Q3 2024.
- On a year-over-year basis, Accounts Payables has declined for three consecutive quarters, with an average decline of 0.4% over the last eight quarters.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 238.7% in Q3 2023, against a decline of 64.9% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.62 million (Q1 2026), $3.02 million (Q4 2025) and $2.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | AN2 Therapeutics | 162.48 Mn | -121.13 Mn | - | 1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 4.88 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 1.06 Mn |
API Access
AN2 Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();